{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T23:30:41Z","timestamp":1780702241565,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100013778","name":"Appendix Cancer Pseudomyxoma Peritonei Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013778","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jacobsen Fund for Cancer Research"},{"name":"Dimmitt Family Cancer Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1245\/s10434-025-16939-0","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T21:02:08Z","timestamp":1740258128000},"page":"3660-3671","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Transcriptomic Landscapes of Appendiceal Primary and Metastatic Tumors are Distinct"],"prefix":"10.1245","volume":"32","author":[{"given":"Margaret A.","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Genilo-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Moran-Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Alhassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer B.","family":"Permuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Imanirad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2012-2238","authenticated-orcid":false,"given":"Sean P.","family":"Dineen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,22]]},"reference":[{"key":"16939_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13023-021-01723-6","volume":"16","author":"YL Lin","year":"2021","unstructured":"Lin YL, Xu DZ, Li XB, Yan FC, Xu HB, Peng Z, Li Y. Consensuses and controversies on pseudomyxoma peritonei: a review of the published consensus statements and guidelines. Orphanet J Rare Dis. 2021;16:85. https:\/\/doi.org\/10.1186\/s13023-021-01723-6.","journal-title":"Orphanet J Rare Dis."},{"key":"16939_CR2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/02656736.2017.1310938","volume":"33","author":"R Mittal","year":"2017","unstructured":"Mittal R, Chandramohan A, Moran B. Pseudomyxoma peritonei: natural history and treatment. Int J Hyperthermia. 2017;33:511\u20139. https:\/\/doi.org\/10.1080\/02656736.2017.1310938. (PubMed PMID: 28540829).","journal-title":"Int J Hyperthermia."},{"key":"16939_CR3","doi-asserted-by":"publisher","first-page":"554910","DOI":"10.3389\/fsurg.2020.554910","volume":"7","author":"S Zhou","year":"2020","unstructured":"Zhou S, Zhao H, He X. The prognostic impact of pathology on patients with pseudomyxoma peritonei undergoing debulking surgery: a systematic review and meta-analysis of retrospective studies. Front Surg. 2020;7:554910. https:\/\/doi.org\/10.3389\/fsurg.2020.554910.","journal-title":"Front Surg."},{"key":"16939_CR4","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1001\/jamasurg.2023.0112.PubMedPMID:36920381;PMCID:PMC10018403","volume":"158","author":"K Chandrakumaran","year":"2023","unstructured":"Chandrakumaran K, Carr NJ, Mohamed F, Cecil TD, Moran BJ. Development and validation of nomograms to predict survival in patients undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin. JAMA Surg. 2023;158:522\u201330. https:\/\/doi.org\/10.1001\/jamasurg.2023.0112.PubMedPMID:36920381;PMCID:PMC10018403.","journal-title":"JAMA Surg."},{"key":"16939_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/EDBK_321009","volume":"41","author":"RS Hoehn","year":"2021","unstructured":"Hoehn RS, Rieser CJ, Choudry MH, Melnitchouk N, Hechtman J, Bahary N. Current management of appendiceal neoplasms. Am Soc Clin Oncol Educ Book. 2021;41:1\u201315. https:\/\/doi.org\/10.1200\/EDBK_321009. (PubMed PMID: 33770459).","journal-title":"Am Soc Clin Oncol Educ Book."},{"key":"16939_CR6","doi-asserted-by":"publisher","first-page":"E71","DOI":"10.1503\/cjs.002519","volume":"63","author":"E Jost","year":"2020","unstructured":"Jost E, Mack LA, Sideris L, Dube P, Temple W, Bouchard-Fortier A. Evaluation of repeat cytoreductive surgery and heated intraperitoneal chemotherapy for patients with recurrent peritoneal carcinomatosis from appendiceal and colorectal cancers: a multicentre Canadian study. Can J Surg. 2020;63:E71\u2013E79. https:\/\/doi.org\/10.1503\/cjs.002519","journal-title":"Can J Surg."},{"key":"16939_CR7","doi-asserted-by":"publisher","unstructured":"Hiraide S, Komine K, Sato Y, Ouchi K, Imai H, Saijo K, et al. Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei. Int J Clin Oncol. 2020;25:774\u201381. Epub 20191210. https:\/\/doi.org\/10.1007\/s10147-019-01592-x. PubMed PMID: 31823151; PMCID: PMC7118031.","DOI":"10.1007\/s10147-019-01592-x"},{"key":"16939_CR8","doi-asserted-by":"publisher","unstructured":"Pietrantonio F, Maggi C, Fanetti G, Iacovelli R, Di Bartolomeo M, Ricchini F, et al. FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma. Oncologist. 2014;19:845\u201350. Epub 20140620. https:\/\/doi.org\/10.1634\/theoncologist.2014-0106. PubMed PMID: 24951608; PMCID: PMC4122474.","DOI":"10.1634\/theoncologist.2014-0106"},{"key":"16939_CR9","doi-asserted-by":"publisher","unstructured":"Munari G, Businello G, Mattiolo P, Pennelli G, Sbaraglia M, Borga C, et al. Molecular profiling of appendiceal serrated lesions, polyps, and mucinous neoplasms: a single-centre experience. J Cancer Res Clin Oncol. 2021;147:1897\u2013904. Epub 20210312. https:\/\/doi.org\/10.1007\/s00432-021-03589-4. PubMed PMID: 33712927; PMCID: PMC8164605.","DOI":"10.1007\/s00432-021-03589-4"},{"key":"16939_CR10","doi-asserted-by":"publisher","unstructured":"Pai RK, Hartman DJ, Gonzalo DH, Lai KK, Downs-Kelly E, Goldblum JR, et al. Serrated lesions of the appendix frequently harbor KRAS mutations and not BRAF mutations indicating a distinctly different serrated neoplastic pathway in the appendix. Hum Pathol. 2014;45:227\u201335. Epub 20131030. https:\/\/doi.org\/10.1016\/j.humpath.2013.10.021. PubMed PMID: 24439221.","DOI":"10.1016\/j.humpath.2013.10.021"},{"key":"16939_CR11","doi-asserted-by":"publisher","unstructured":"Singhi AD, Davison JM, Choudry HA, Pingpank JF, Ahrendt SA, Holtzman MP, et al. GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival. Hum Pathol. 2014;45:1737\u201343. Epub 20140508. https:\/\/doi.org\/10.1016\/j.humpath.2014.04.018. PubMed PMID: 24925222.","DOI":"10.1016\/j.humpath.2014.04.018"},{"key":"16939_CR12","doi-asserted-by":"publisher","unstructured":"Levine EA, Votanopoulos KI, Qasem SA, Philip J, Cummins KA, Chou JW, et al. Prognostic molecular subtypes of low-grade cancer of the appendix. J Am Coll Surg. 2016;222:493\u2013503. Epub 20151221. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2015.12.012. PubMed PMID: 26821970; PMCID: PMC4808611.","DOI":"10.1016\/j.jamcollsurg.2015.12.012"},{"key":"16939_CR13","doi-asserted-by":"publisher","unstructured":"Su J, Jin G, Votanopoulos KI, Craddock L, Shen P, Chou JW, et al. Prognostic molecular classification of appendiceal mucinous neoplasms treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2020;27:1439\u201347. Epub 20200124. https:\/\/doi.org\/10.1245\/s10434-020-08210-5. PubMed PMID: 31980985; PMCID: PMC7147286.","DOI":"10.1245\/s10434-020-08210-5"},{"key":"16939_CR14","doi-asserted-by":"publisher","unstructured":"Stewart RL, Matynia AP, Factor RE, Varley KE. Spatially resolved quantification of proteins in triple-negative breast cancers reveals differences in the immune microenvironment associated with prognosis. Sci Rep. 2020;10:6598. Epub 20200420. https:\/\/doi.org\/10.1038\/s41598-020-63539-x. PubMed PMID: 32313087; PMCID: PMC7170957.","DOI":"10.1038\/s41598-020-63539-x"},{"key":"16939_CR15","doi-asserted-by":"publisher","unstructured":"Zugazagoitia J, Gupta S, Liu Y, Fuhrman K, Gettinger S, Herbst RS, et al. Biomarkers associated with beneficial PD-1 checkpoint blockade in non-small cell lung cancer (NSCLC) identified using high-plex digital spatial profiling. Clin Cancer Res. 2020;26:4360\u20138. Epub 20200406. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-0175. PubMed PMID: 32253229; PMCID: PMC7442721.","DOI":"10.1158\/1078-0432.CCR-20-0175"},{"key":"16939_CR16","doi-asserted-by":"publisher","unstructured":"Berrell N, Monkman J, Donovan M, Blick T, O'Byrne K, Ladwa R, et al. Spatial resolution of the head and neck cancer tumor microenvironment to identify tumor and stromal features associated with therapy response. Immunol Cell Biol. 2024;102:830\u201346. Epub 20240724. https:\/\/doi.org\/10.1111\/imcb.12811. PubMed PMID: 39048134.","DOI":"10.1111\/imcb.12811"},{"key":"16939_CR17","doi-asserted-by":"publisher","unstructured":"Ang CS, Shen JP, Hardy-Abeloos CJ, Huang JK, Ross JS, Miller VA, et al. Genomic landscape of appendiceal neoplasms. JCO Precis Oncol. 2018 Aug 8;2:PO.17.00302. https:\/\/doi.org\/10.1200\/PO.17.00302. PubMed PMID: 32913983; PMCID: PMC7446344.","DOI":"10.1200\/PO.17.00302"},{"key":"16939_CR18","doi-asserted-by":"publisher","unstructured":"Glyn T, Williams S, Whitehead M, Eglinton T, West N, Purcell RV. Digital spatial profiling identifies molecular changes involved in development of colitis-associated colorectal cancer. Front Oncol. 2024;14:1247106. Epub 20240304. https:\/\/doi.org\/10.3389\/fonc.2024.1247106. PubMed PMID: 38505585; PMCID: PMC10949367.","DOI":"10.3389\/fonc.2024.1247106"},{"issue":"6","key":"16939_CR19","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.3390\/cancers15061701","volume":"15","author":"S Hernandez","year":"2023","unstructured":"Hernandez S, Das P, Holliday EB, Shen L, Lu W, Johnson B, et al. Differential spatial gene and protein expression associated with recurrence following chemoradiation for localized anal squamous cell cancer. Cancers Basel. 2023;15(6):1701. https:\/\/doi.org\/10.3390\/cancers15061701. PubMed PMID: 36980587; PMCID: PMC10046657.","journal-title":"Cancers Basel."},{"key":"16939_CR20","doi-asserted-by":"publisher","unstructured":"Huang KK, Ma H, Chong RHH, Uchihara T, Lian BSX, Zhu F, et al. Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression. Cancer Cell. 2023;41:2019\u201337 e8. Epub 20231026. https:\/\/doi.org\/10.1016\/j.ccell.2023.10.004. PubMed PMID: 37890493; PMCID: PMC10729843.","DOI":"10.1016\/j.ccell.2023.10.004"},{"key":"16939_CR21","doi-asserted-by":"publisher","unstructured":"Hernandez S, Lazcano R, Serrano A, Powell S, Kostousov L, Mehta J, et al. Challenges and opportunities for immunoprofiling using a spatial high-plex technology: the NanoString GeoMx((R)) Digital Spatial Profiler. Front Oncol. 2022;12:890410. Epub 20220629. https:\/\/doi.org\/10.3389\/fonc.2022.890410. PubMed PMID: 35847846; PMCID: PMC9277770.","DOI":"10.3389\/fonc.2022.890410"},{"key":"16939_CR22","doi-asserted-by":"publisher","unstructured":"Zimmerman SM, Fropf R, Kulasekara BR, Griswold M, Appelbe O, Bahrami A, et al. Spatially resolved whole transcriptome profiling in human and mouse tissue using Digital Spatial Profiling. Genome Res. 2022;32:1892\u2013905. Epub 20220913. https:\/\/doi.org\/10.1101\/gr.276206.121. PubMed PMID: 36100434; PMCID: PMC9712633.","DOI":"10.1101\/gr.276206.121"},{"key":"16939_CR23","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8.PubMedPMID:25516281;PMCID:PMC4302049","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.PubMedPMID:25516281;PMCID:PMC4302049.","journal-title":"Genome Biol."},{"key":"16939_CR24","doi-asserted-by":"publisher","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation Camb. 2021;2:100141. Epub 20210701. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141. PubMed PMID: 34557778; PMCID: PMC8454663.","DOI":"10.1016\/j.xinn.2021.100141"},{"key":"16939_CR25","doi-asserted-by":"publisher","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137. Epub 20120328. https:\/\/doi.org\/10.1089\/omi.2011.0118. PubMed PMID: 22455463; PMCID: PMC3339379.","DOI":"10.1089\/omi.2011.0118"},{"key":"16939_CR26","doi-asserted-by":"publisher","unstructured":"Eide PW, Bruun J, Lothe RA, Sveen A. CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models. Sci Rep. 2017;7:16618. Epub 20171130. https:\/\/doi.org\/10.1038\/s41598-017-16747-x. PubMed PMID: 29192179; PMCID: PMC5709354.","DOI":"10.1038\/s41598-017-16747-x"},{"key":"16939_CR27","doi-asserted-by":"publisher","unstructured":"Roelands J, van der Ploeg M, Ijsselsteijn ME, Dang H, Boonstra JJ, Hardwick JCH, et al. Transcriptomic and immunophenotypic profiling reveals molecular and immunological hallmarks of colorectal cancer tumourigenesis. Gut. 2023;72:1326\u201339. Epub 20221128. https:\/\/doi.org\/10.1136\/gutjnl-2022-327608. PubMed PMID: 36442992; PMCID: PMC10314051.","DOI":"10.1136\/gutjnl-2022-327608"},{"key":"16939_CR28","unstructured":"Bast RC Jr, Byrd JC, Croce CM, Hawk ET, Khuri FR, Pollock RE, et al. Holland Frei Cancer Medicine 10. 10th ed. Wiley-Blackwell, Hoboken, NJ, 2023."},{"key":"16939_CR29","doi-asserted-by":"publisher","unstructured":"Plava J, Cihova M, Burikova M, Matuskova M, Kucerova L, Miklikova S. Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer. Mol Cancer. 2019;18:67. Epub 20190330. https:\/\/doi.org\/10.1186\/s12943-019-0960-z. PubMed PMID: 30927930; PMCID: PMC6441200.","DOI":"10.1186\/s12943-019-0960-z"},{"key":"16939_CR30","doi-asserted-by":"publisher","unstructured":"Benson AB III, Wainberg ZA, Hecht JR, Vyushkov D, Dong H, Bendell J, Kudrik F. A phase II randomized, double-blind, placebo-controlled study of simtuzumab or placebo in combination with gemcitabine for the first-line treatment of pancreatic adenocarcinoma. Oncologist. 2017;22:241\u2013e15. Epub 20170228. https:\/\/doi.org\/10.1634\/theoncologist.2017-0024. PubMed PMID: 28246206; PMCID: PMC5344644.","DOI":"10.1634\/theoncologist.2017-0024"},{"key":"16939_CR31","doi-asserted-by":"publisher","unstructured":"Hecht JR, Benson AB III, Vyushkov D, Yang Y, Bendell J, Verma U. A phase II, randomized, double-blind, placebo-controlled study of simtuzumab in combination with FOLFIRI for the second-line treatment of metastatic KRAS mutant colorectal adenocarcinoma. Oncologist. 2017;22:243\u2013e23. Epub 20170228. https:\/\/doi.org\/10.1634\/theoncologist.2016-0479. PubMed PMID: 28246207; PMCID: PMC5344646.","DOI":"10.1634\/theoncologist.2016-0479"},{"key":"16939_CR32","doi-asserted-by":"publisher","unstructured":"Arias-Lorza AM, Costello JR, Hingorani SR, Von Hoff DD, Korn RL, Raghunand N. Tumor response to stroma-modifying therapy: magnetic resonance imaging findings in early-phase clinical trials of pegvorhyaluronidase alpha (PEGPH20). Res Sq. 2023. Sep 5:rs.3.rs-3314770. https:\/\/doi.org\/10.21203\/rs.3.rs-3314770\/v1. PubMed PMID: 37720027; PMCID: PMC10503830.","DOI":"10.21203\/rs.3.rs-3314770\/v1"},{"key":"16939_CR33","doi-asserted-by":"publisher","unstructured":"Shimizu T, Fukuoka K, Takeda M, Iwasa T, Yoshida T, Horobin J, et al. A first-in-Asian phase 1 study to evaluate safety, pharmacokinetics, and clinical activity of VS-6063, a focal adhesion kinase (FAK) inhibitor in Japanese patients with advanced solid tumors. Cancer Chemother Pharmacol. 2016;77:997\u20131003. Epub 20160330. https:\/\/doi.org\/10.1007\/s00280-016-3010-1. PubMed PMID: 27025608; PMCID: PMC4844649.","DOI":"10.1007\/s00280-016-3010-1"},{"key":"16939_CR34","doi-asserted-by":"publisher","unstructured":"Fard D, Giraudo E, Tamagnone L. Mind the (guidance) signals! Translational relevance of semaphorins, plexins, and neuropilins in pancreatic cancer. Trends Mol Med. 2023;29:817\u201329. Epub 20230817. https:\/\/doi.org\/10.1016\/j.molmed.2023.07.009. PubMed PMID: 37598000.","DOI":"10.1016\/j.molmed.2023.07.009"},{"key":"16939_CR35","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1128\/MCB.21.13.4246-4255.2001.PubMedPMID:11390653;PMCID:PMC87085","volume":"21","author":"DG Pestov","year":"2001","unstructured":"Pestov DG, Strezoska Z, Lau LF. Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)\/S transition. Mol Cell Biol. 2001;21:4246\u201355. https:\/\/doi.org\/10.1128\/MCB.21.13.4246-4255.2001.PubMedPMID:11390653;PMCID:PMC87085.","journal-title":"Mol Cell Biol."},{"key":"16939_CR36","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1158\/0008-5472.CAN-21-4087.PubMedPMID:35303060;PMCID:PMC9256764","volume":"82","author":"AR Elhamamsy","year":"2022","unstructured":"Elhamamsy AR, Metge BJ, Alsheikh HA, Shevde LA, Samant RS. Ribosome biogenesis: a central player in cancer metastasis and therapeutic resistance. Cancer Res. 2022;82:2344\u201353. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-4087.PubMedPMID:35303060;PMCID:PMC9256764.","journal-title":"Cancer Res."},{"key":"16939_CR37","first-page":"211","volume":"25","author":"J Liu","year":"2018","unstructured":"Liu J, Shen JX, Wu HT, Li XL, Wen XF, Du CW, Zhang GJ. Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target. Discov Med. 2018;25:211\u201323 (PubMed PMID: 29906404).","journal-title":"Discov Med."},{"issue":"17","key":"16939_CR38","doi-asserted-by":"publisher","first-page":"e146133","DOI":"10.1172\/jci.insight.146133","volume":"6","author":"J Deng","year":"2021","unstructured":"Deng J, Kang Y, Cheng CC, Li X, Dai B, Katz MH, et al. DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis. JCI Insight. 2021;6(17):e146133. https:\/\/doi.org\/10.1172\/jci.insight.146133. PubMed PMID: 34237033; PMCID: PMC8492346.","journal-title":"JCI Insight."},{"key":"16939_CR39","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.3390\/cancers14143396","volume":"14","author":"M Lindgren","year":"2022","unstructured":"Lindgren M, Rask G, Jonsson J, Berglund A, Lundin C, Jonsson P, et al. Type IV collagen in human colorectal liver metastases: cellular origin and a circulating biomarker. Cancers Basel. 2022;14:3396. https:\/\/doi.org\/10.3390\/cancers14143396. PubMed PMID: 35884455; PMCID: PMC9325127.","journal-title":"Cancers Basel."},{"key":"16939_CR40","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.3390\/cancers14194706","volume":"14","author":"S Baldari","year":"2022","unstructured":"Baldari S, Di Modugno F, Nistico P, Toietta G. Strategies for efficient targeting of tumor collagen for cancer therapy. Cancers Basel. 2022;14:4706. https:\/\/doi.org\/10.3390\/cancers14194706. PubMed PMID: 36230627; PMCID: PMC9563908.","journal-title":"Cancers Basel."},{"key":"16939_CR41","doi-asserted-by":"publisher","first-page":"a011908","DOI":"10.1101\/cshperspect.a011908","volume":"4","author":"P Nistico","year":"2012","unstructured":"Nistico P, Bissell MJ, Radisky DC. Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases. Cold Spring Harb Perspect Biol. 2012;4:a011908. https:\/\/doi.org\/10.1101\/cshperspect.a011908. PubMed PMID: 22300978; PMCID: PMC3281569.","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"16939_CR42","doi-asserted-by":"publisher","unstructured":"Kim YN, Koo KH, Sung JY, Yun UJ, Kim H. Anoikis resistance: an essential prerequisite for tumor metastasis. Int J Cell Biol. 2012;2012:306879. Epub 20120223. https:\/\/doi.org\/10.1155\/2012\/306879. PubMed PMID: 22505926; PMCID: PMC3296207.","DOI":"10.1155\/2012\/306879"},{"key":"16939_CR43","doi-asserted-by":"publisher","unstructured":"Simpson CD, Anyiwe K, Schimmer AD. Anoikis resistance and tumor metastasis. Cancer Lett. 2008;272:177\u201385. Epub 20080624. https:\/\/doi.org\/10.1016\/j.canlet.2008.05.029. PubMed PMID: 18579285.","DOI":"10.1016\/j.canlet.2008.05.029"},{"key":"16939_CR44","doi-asserted-by":"publisher","unstructured":"Sharma E, Gokani SA, Neville J, Sinha A, Agarwal T. Mucinous appendiceal adenocarcinomas: a diagnostic challenge. J Surg Case Rep. 2020;2020:rjz355. Epub 20200122. https:\/\/doi.org\/10.1093\/jscr\/rjz355. PubMed PMID: 31988709; PMCID: PMC6975158.","DOI":"10.1093\/jscr\/rjz355"},{"key":"16939_CR45","doi-asserted-by":"publisher","unstructured":"Soni TP, Sharma P, Sharma A, Ledwani N. Low-grade mucinous appendiceal neoplasm: a tumor in disguise of appendicitis. J Gastrointest Cancer. 2021;52:1134\u20138. Epub 20210211. https:\/\/doi.org\/10.1007\/s12029-021-00593-2. PubMed PMID: 33570710.","DOI":"10.1007\/s12029-021-00593-2"},{"key":"16939_CR46","doi-asserted-by":"publisher","unstructured":"Stein S, Raymond DOB. Appendiceal adenocarcinoma presenting as perforated appendicitis. Cureus. 2021;13:e13578. Epub 20210226. https:\/\/doi.org\/10.7759\/cureus.13578. PubMed PMID: 33815986; PMCID: PMC8009447.","DOI":"10.7759\/cureus.13578"},{"key":"16939_CR47","doi-asserted-by":"publisher","unstructured":"Nie MJ, Pan XT, Tao HY, Xu MJ, Liu SL, Sun W, et al. Clinical and prognostic significance of MYH11 in lung cancer. Oncol Lett. 2020;19:3899\u2013906. Epub 20200327. https:\/\/doi.org\/10.3892\/ol.2020.11478. PubMed PMID: 32382337; PMCID: PMC7202280.","DOI":"10.3892\/ol.2020.11478"},{"key":"16939_CR48","doi-asserted-by":"publisher","unstructured":"Gonzalez L, Eiro N, Gonzalez-Reyes S, Andicoechea A, Gonzalez LO, Garcia-Muniz JL, Vizoso FJ. Clinical significance of myosin in colorectal cancer. Ann Diagn Pathol. 2012;16:260\u20136. Epub 20120323. https:\/\/doi.org\/10.1016\/j.anndiagpath.2011.11.004. PubMed PMID: 22445363.","DOI":"10.1016\/j.anndiagpath.2011.11.004"},{"key":"16939_CR49","doi-asserted-by":"publisher","unstructured":"Alhopuro P, Phichith D, Tuupanen S, Sammalkorpi H, Nybondas M, Saharinen J, et al. Unregulated smooth-muscle myosin in human intestinal neoplasia. Proc Natl Acad Sci U S A. 2008;105:5513\u20138. Epub 20080407. https:\/\/doi.org\/10.1073\/pnas.0801213105. PubMed PMID: 18391202; PMCID: PMC2291082.","DOI":"10.1073\/pnas.0801213105"},{"key":"16939_CR50","doi-asserted-by":"publisher","unstructured":"Naydenov NG, Lechuga S, Huang EH, Ivanov AI. Myosin motors: novel regulators and therapeutic targets in colorectal cancer. Cancers Basel. 2021;13. Epub 20210211. https:\/\/doi.org\/10.3390\/cancers13040741. PubMed PMID: 33670106; PMCID: PMC7916823.","DOI":"10.3390\/cancers13040741"},{"key":"16939_CR51","doi-asserted-by":"publisher","unstructured":"Pervaz S, Ullah A, Adu-Gyamfi EA, Lamptey J, Sah SK, Wang MJ, Wang YX. Role of CPXM1 in impaired glucose metabolism and ovarian dysfunction in polycystic ovary syndrome. Reprod Sci. 2023;30:526\u201343. Epub 20220613. https:\/\/doi.org\/10.1007\/s43032-022-00987-y. PubMed PMID: 35697923.","DOI":"10.1007\/s43032-022-00987-y"},{"key":"16939_CR52","doi-asserted-by":"publisher","unstructured":"Gu Q, Mi L, Lai C, Guan X, Lu N, Zhan T, et al. CPXM1 correlates to poor prognosis and immune cell infiltration in gastric cancer. Heliyon. 2024;10:e21909. Epub 20231111. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21909. PubMed PMID: 38314284; PMCID: PMC10837494.","DOI":"10.1016\/j.heliyon.2023.e21909"},{"key":"16939_CR53","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.3390\/cancers13133343","volume":"13","author":"M Zheng","year":"2021","unstructured":"Zheng M, Long J, Chelariu-Raicu A, Mullikin H, Vilsmaier T, Vattai A, et al. Identification of a novel tumor microenvironment prognostic signature for advanced-stage serous ovarian cancer. Cancers Basel. 2021;13:3343. https:\/\/doi.org\/10.3390\/cancers13133343. PubMed PMID: 34283076; PMCID: PMC8268985.","journal-title":"Cancers Basel."},{"key":"16939_CR54","doi-asserted-by":"publisher","unstructured":"van Hijfte L, Geurts M, Vallentgoed WR, Eilers PHC, Sillevis Smitt PAE, Debets R, French PJ. Alternative normalization and analysis pipeline to address systematic bias in NanoString GeoMx Digital Spatial Profiling data. iScience. 2023;26:105760. Epub 20221209. https:\/\/doi.org\/10.1016\/j.isci.2022.105760. PubMed PMID: 36590163; PMCID: PMC9800292.","DOI":"10.1016\/j.isci.2022.105760"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-16939-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-16939-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-16939-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T07:04:28Z","timestamp":1744095868000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-16939-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,22]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["16939"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-16939-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,22]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}